MediWound Ltd. (MDWD)
12.55
+0.48
(+4.02%)
USD |
NASDAQ |
Oct 27, 16:00
12.61
+0.06
(+0.48%)
After-Hours: 20:00
MediWound Enterprise Value : 136.22M for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 136.22M |
| October 26, 2026 | 129.96M |
| October 23, 2026 | 129.12M |
| October 22, 2026 | 131.44M |
| October 21, 2026 | 130.41M |
| October 20, 2026 | 130.41M |
| October 19, 2026 | 138.16M |
| October 16, 2026 | 127.18M |
| October 15, 2026 | 131.83M |
| October 14, 2026 | 127.96M |
| October 13, 2026 | 131.96M |
| October 12, 2026 | 136.35M |
| October 09, 2026 | 136.09M |
| October 08, 2026 | 134.54M |
| October 07, 2026 | 140.09M |
| October 06, 2026 | 143.97M |
| October 05, 2026 | 148.61M |
| October 02, 2026 | 148.74M |
| October 01, 2026 | 149.78M |
| September 30, 2026 | 151.97M |
| September 29, 2026 | 152.36M |
| September 28, 2026 | 154.04M |
| September 25, 2026 | 152.87M |
| September 24, 2026 | 152.75M |
| September 23, 2026 | 150.42M |
| Date | Value |
|---|---|
| September 22, 2026 | 154.29M |
| September 21, 2026 | 146.03M |
| September 18, 2026 | 147.19M |
| September 17, 2026 | 146.55M |
| September 16, 2026 | 144.87M |
| September 15, 2026 | 148.10M |
| September 14, 2026 | 153.39M |
| September 11, 2026 | 143.45M |
| September 10, 2026 | 151.20M |
| September 09, 2026 | 152.87M |
| September 08, 2026 | 147.71M |
| September 04, 2026 | 145.77M |
| September 03, 2026 | 144.74M |
| September 02, 2026 | 142.80M |
| September 01, 2026 | 137.12M |
| August 31, 2026 | 136.99M |
| August 28, 2026 | 137.64M |
| August 27, 2026 | 145.13M |
| August 26, 2026 | 138.16M |
| August 25, 2026 | 141.64M |
| August 24, 2026 | 142.03M |
| August 21, 2026 | 144.74M |
| August 20, 2026 | 143.51M |
| August 19, 2026 | 149.65M |
| August 18, 2026 | 150.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 60.28B |
| RedHill Biopharma Ltd. | -11.14M |
| Purple Biotech Ltd. | -4.534M |
| Sol-Gel Technologies Ltd. | 176.10M |
| PolyPid Ltd. | 112.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.392M |
| Revenue (Quarterly) | 3.092M |
| Total Expenses (Quarterly) | 10.48M |
| EPS Diluted (Quarterly) | -0.5737 |
| Gross Profit Margin (Quarterly) | 10.90% |
| Profit Margin (Quarterly) | -239.1% |
| Earnings Yield | -12.78% |
| Normalized Earnings Yield | -12.78 |